/GUBRA.CO
GUBRA.CO Stock - Gubra A/S
Healthcare|BiotechnologyCPH
$517.00+1.17%
+$6.00 (+1.17%) • Dec 23
77
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.BUY
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.93
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.96
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $568.70
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for GUBRA.CO
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$511.83 – $522.17
TARGET (TP)$594.55
STOP LOSS$475.64
RISK/REWARD1:1.9
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta0.59
52W High$730.00
52W Low$318.40
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $265.74M | $205.00M | $199.38M | $255.33M | $172.30M |
| Gross Profit | $164.50M | $114.94M | $97.75M | $165.88M | $92.35M |
| Gross Margin | 61.9% | 56.1% | 49.0% | 65.0% | 53.6% |
| Operating Income | $-50,011,000 | $-49,417,000 | $-17,692,000 | $88.79M | $15.82M |
| Net Income | $-36,498,000 | $-44,524,000 | $4.31M | $67.94M | $12.69M |
| Net Margin | -13.7% | -21.7% | 2.2% | 26.6% | 7.4% |
| EPS | $-2.24 | $-2.93 | $0.26 | $4.16 | $0.78 |
Company Overview
Gubra A/S operates as a biotech company with two primary areas of business: pre-clinical contract research (CRO) services and proprietary early target and drug discovery programs. The CRO segment offers pre-clinical contract research and development services for the pharmaceutical and biotechnology industry, as well as provides services in vivo pharmacology, tissue research, assays, molecular pharmacology, bioanalysis, sequencing (NGS), and 2D and 3D imaging. The company was incorporated in 2008 and is based in Horsholm, Denmark.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
GUBRA.COBeat Rate
0%
Last 1 quarters
Avg Surprise
-26.5%
EPS vs Estimate
Beats / Misses
0/1
Last 12 quarters
Latest EPS
$107.10
Q3 2025
EPS Surprise History
Q4 21
No data
Q2 22
No data
Q4 22
No data
Q2 23
No data
Q4 23
No data
Q4 24
No data
Q2 25
No data
Q3 25
-26.5%
$107.10vs$145.77
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q1 2026 | Feb 27, 2026 | — | — | — | — |
Q3 2025 | Aug 21, 2025 | $145.77 | $107.10 | -26.5% | ✗ MISS |
Q2 2025 | May 9, 2025 | — | $-1.00 | — | — |
Q4 2024 | Nov 7, 2024 | — | $-1.20 | — | — |
Q4 2023 | Dec 31, 2023 | — | $-1.62 | — | — |
Q2 2023 | Jun 30, 2023 | — | $-1.29 | — | — |
Q4 2022 | Dec 31, 2022 | — | $0.95 | — | — |
Q2 2022 | Jun 30, 2022 | — | $-0.58 | — | — |
Q4 2021 | Dec 31, 2021 | — | $2.08 | — | — |
Q2 2021 | Jun 30, 2021 | — | $2.08 | — | — |
Q4 2020 | Dec 31, 2020 | — | $0.39 | — | — |
Q2 2020 | Jun 30, 2020 | — | $0.39 | — | — |
Latest News
Loading news...
Frequently Asked Questions about GUBRA.CO
What is GUBRA.CO's current stock price?
Gubra A/S (GUBRA.CO) is currently trading at $517.00 per share. The stock has moved +1.17% today.
What is the analyst price target for GUBRA.CO?
No analyst price targets are currently available for this stock.
What sector is Gubra A/S in?
Gubra A/S operates in the Healthcare sector, specifically within the Biotechnology industry. The company is traded on the CPH exchange.
What is GUBRA.CO's market cap?
Gubra A/S has a market capitalization of $8.45 billion, making it a mid-cap company.
Does GUBRA.CO pay dividends?
No, Gubra A/S does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorBAVA.CO
Bavarian Nordic A/S
$189.45
Mkt Cap: $14.8B
BIOPOR.CO
BioPorto A/S
$1.04
Mkt Cap: $0.5B
BRAINP.CO
Brain+ A/S
$0.01
Mkt Cap: $0.0B
CHEMM.CO
ChemoMetec A/S
$683.50
Mkt Cap: $11.9B
MONSO.CO
Monsenso A/S
$0.16
Mkt Cap: $0.0B
PEG.CO
Pharma Equity Group A/S
$0.09
Mkt Cap: $0.1B
SMSMED.CO
Scandinavian Medical Solutions A/S
$4.75
Mkt Cap: $0.1B
STENO.CO
Stenocare A/S
$1.47
Mkt Cap: $0.1B
VIRO.CO
ViroGates A/S
$12.05
Mkt Cap: $0.1B
ZEAL.CO
Zealand Pharma A/S
$483.00
Mkt Cap: $34.1B
Explore stocks similar to GUBRA.CO for comparison